Acutus Medical Inc
OTC:AFIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Acutus Medical Inc
OTC:AFIB
|
US |
|
Unisync Corp
TSX:UNI
|
CA |
|
Adeia Inc
NASDAQ:ADEA
|
US |
|
Babylon Holdings Ltd
OTC:BBLNF
|
US |
|
B
|
BurTech Acquisition Corp
NASDAQ:BRKH
|
US |
|
Naturhouse Health SA
F:2NH
|
ES |
|
Gilead Sciences Inc
NASDAQ:GILD
|
US |
|
Alliance Media Holdings Inc
OTC:ADTR
|
US |
|
Kuke Music Holding Ltd
NYSE:KUKE
|
CN |
|
T
|
Translational Development Acquisition Corp
NASDAQ:TDAC
|
US |
|
W
|
WoojinNTec Inc
KOSDAQ:457550
|
KR |
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
KR |
|
Dynacor Gold Mines Inc
TSX:DNG
|
CA |
|
Centrepoint Alliance Ltd
ASX:CAF
|
AU |
|
Bigben Interactive SA
PAR:BIG
|
FR |
|
Vection Technologies Ltd
ASX:VR1
|
AU |
|
Aegis Brands Inc
TSX:AEG
|
CA |
|
Union Gas Holdings Ltd
SGX:1F2
|
SG |
|
PDD Holdings Inc
NASDAQ:PDD
|
CN |
|
T
|
Telesat Corp
NASDAQ:TSAT
|
CA |
|
ODP Corp
NASDAQ:ODP
|
US |
|
Merko Ehitus AS
F:MKS
|
EE |
|
Monro Inc
NASDAQ:MNRO
|
US |
|
International Flavors & Fragrances Inc
NYSE:IFF
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AFIB's stock price target?
Not Available
AFIB doesn't have any price targets made by Wall Street professionals.
What is Acutus Medical Inc's Revenue forecast?
Projected CAGR
150%
For the last 5 years the
compound annual growth rate for
Acutus Medical Inc's revenue is
48%.
The projected
CAGR
for the next 1 year is
150%.